203 related articles for article (PubMed ID: 35716883)
21. Lipid nanoparticles containing labile PEG-lipids transfect primary human skin cells more efficiently in the presence of apoE.
Gregersen CH; Mearraoui R; Søgaard PP; Clergeaud G; Petersson K; Urquhart AJ; Simonsen JB
Eur J Pharm Biopharm; 2024 Apr; 197():114219. PubMed ID: 38368913
[TBL] [Abstract][Full Text] [Related]
22. Effect of the nanoformulation of siRNA-lipid assemblies on their cellular uptake and immune stimulation.
Kubota K; Onishi K; Sawaki K; Li T; Mitsuoka K; Sato T; Takeoka S
Int J Nanomedicine; 2017; 12():5121-5133. PubMed ID: 28790820
[TBL] [Abstract][Full Text] [Related]
23. Continuous production of lipid nanoparticles by multiple-splitting in microfluidic devices with chaotic microfibrous channels.
Ahn GY; Choi I; Ryu TK; Ryu YH; Oh DH; Kang HW; Kang MH; Choi SW
Colloids Surf B Biointerfaces; 2023 Apr; 224():113212. PubMed ID: 36822116
[TBL] [Abstract][Full Text] [Related]
24. Lipid Microparticles Show Similar Efficacy With Lipid Nanoparticles in Delivering mRNA and Preventing Cancer.
Ji A; Xu M; Pan Y; Diao L; Ma L; Qian L; Cheng J; Liu M
Pharm Res; 2023 Jan; 40(1):265-279. PubMed ID: 36451070
[TBL] [Abstract][Full Text] [Related]
25. Formulating and Characterizing Lipid Nanoparticles for Gene Delivery using a Microfluidic Mixing Platform.
Bailey-Hytholt CM; Ghosh P; Dugas J; Zarraga IE; Bandekar A
J Vis Exp; 2021 Feb; (168):. PubMed ID: 33720139
[TBL] [Abstract][Full Text] [Related]
26. Microfluidic hydrodynamic focusing synthesis of polymer-lipid nanoparticles for siRNA delivery.
Huang X; Lee RJ; Qi Y; Li Y; Lu J; Meng Q; Teng L; Xie J
Oncotarget; 2017 Nov; 8(57):96826-96836. PubMed ID: 29228574
[TBL] [Abstract][Full Text] [Related]
27. Manufacturing Considerations for the Development of Lipid Nanoparticles Using Microfluidics.
Roces CB; Lou G; Jain N; Abraham S; Thomas A; Halbert GW; Perrie Y
Pharmaceutics; 2020 Nov; 12(11):. PubMed ID: 33203082
[TBL] [Abstract][Full Text] [Related]
28. Single-step microfluidic synthesis of transferrin-conjugated lipid nanoparticles for siRNA delivery.
Li Y; Lee RJ; Huang X; Li Y; Lv B; Wang T; Qi Y; Hao F; Lu J; Meng Q; Teng L; Zhou Y; Xie J; Teng L
Nanomedicine; 2017 Feb; 13(2):371-381. PubMed ID: 27720989
[TBL] [Abstract][Full Text] [Related]
29. Scalable mRNA and siRNA Lipid Nanoparticle Production Using a Parallelized Microfluidic Device.
Shepherd SJ; Warzecha CC; Yadavali S; El-Mayta R; Alameh MG; Wang L; Weissman D; Wilson JM; Issadore D; Mitchell MJ
Nano Lett; 2021 Jul; 21(13):5671-5680. PubMed ID: 34189917
[TBL] [Abstract][Full Text] [Related]
30. Advances in microfluidics for lipid nanoparticles and extracellular vesicles and applications in drug delivery systems.
Maeki M; Kimura N; Sato Y; Harashima H; Tokeshi M
Adv Drug Deliv Rev; 2018 Mar; 128():84-100. PubMed ID: 29567396
[TBL] [Abstract][Full Text] [Related]
31. Microfluidic Production and Application of Lipid Nanoparticles for Nucleic Acid Transfection.
Thomas A; M Garg S; De Souza RAG; Ouellet E; Tharmarajah G; Reichert D; Ordobadi M; Ip S; Ramsay EC
Methods Mol Biol; 2018; 1792():193-203. PubMed ID: 29797261
[TBL] [Abstract][Full Text] [Related]
32. PEG-OligoRNA Hybridization of mRNA for Developing Sterically Stable Lipid Nanoparticles toward In Vivo Administration.
Kurimoto S; Yoshinaga N; Igarashi K; Matsumoto Y; Cabral H; Uchida S
Molecules; 2019 Apr; 24(7):. PubMed ID: 30987102
[TBL] [Abstract][Full Text] [Related]
33. Size-controlled lipid nanoparticle production using turbulent mixing to enhance oral DNA delivery.
He Z; Hu Y; Nie T; Tang H; Zhu J; Chen K; Liu L; Leong KW; Chen Y; Mao HQ
Acta Biomater; 2018 Nov; 81():195-207. PubMed ID: 30267888
[TBL] [Abstract][Full Text] [Related]
34. Preparation of selective organ-targeting (SORT) lipid nanoparticles (LNPs) using multiple technical methods for tissue-specific mRNA delivery.
Wang X; Liu S; Sun Y; Yu X; Lee SM; Cheng Q; Wei T; Gong J; Robinson J; Zhang D; Lian X; Basak P; Siegwart DJ
Nat Protoc; 2023 Jan; 18(1):265-291. PubMed ID: 36316378
[TBL] [Abstract][Full Text] [Related]
35. The development of an in vitro assay to screen lipid based nanoparticles for siRNA delivery.
Zhang Y; Arrington L; Boardman D; Davis J; Xu Y; DiFelice K; Stirdivant S; Wang W; Budzik B; Bawiec J; Deng J; Beutner G; Seifried D; Stanton M; Gindy M; Leone A
J Control Release; 2014 Jan; 174():7-14. PubMed ID: 24240015
[TBL] [Abstract][Full Text] [Related]
36. Ready-to-Use-Type Lyophilized Lipid Nanoparticle Formulation for the Postencapsulation of Messenger RNA.
Tanaka H; Hagiwara S; Shirane D; Yamakawa T; Sato Y; Matsumoto C; Ishizaki K; Hishinuma M; Chida K; Sasaki K; Yonemochi E; Ueda K; Higashi K; Moribe K; Tadokoro T; Maenaka K; Taneichi S; Nakai Y; Tange K; Sakurai Y; Akita H
ACS Nano; 2023 Feb; 17(3):2588-2601. PubMed ID: 36719091
[TBL] [Abstract][Full Text] [Related]
37. Electrophoretic Microfluidic Characterization of mRNA- and pDNA-Loaded Lipid Nanoparticles.
De Peña AC; Zimmer D; Gutterman-Johns E; Chen NM; Tripathi A; Bailey-Hytholt CM
ACS Appl Mater Interfaces; 2024 May; 16(21):26984-26997. PubMed ID: 38753459
[TBL] [Abstract][Full Text] [Related]
38. Rapid discovery of potent siRNA-containing lipid nanoparticles enabled by controlled microfluidic formulation.
Chen D; Love KT; Chen Y; Eltoukhy AA; Kastrup C; Sahay G; Jeon A; Dong Y; Whitehead KA; Anderson DG
J Am Chem Soc; 2012 Apr; 134(16):6948-51. PubMed ID: 22475086
[TBL] [Abstract][Full Text] [Related]
39. Biodegradable Lipid-Modified Poly(Guanidine Thioctic Acid)s: A Fortifier of Lipid Nanoparticles to Promote the Efficacy and Safety of mRNA Cancer Vaccines.
Yang K; Bai B; Lei J; Yu X; Qi S; Wang Y; Huang F; Tong Z; Yu G
J Am Chem Soc; 2024 May; 146(17):11679-11693. PubMed ID: 38482849
[TBL] [Abstract][Full Text] [Related]
40. Lipid Nanoparticles Optimized for Targeting and Release of Nucleic Acid.
Jia Y; Wang X; Li L; Li F; Zhang J; Liang XJ
Adv Mater; 2024 Jan; 36(4):e2305300. PubMed ID: 37547955
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
